Pharmaceuticals
With Pfizer Firmly in Value Territory, Here's What Investors Are Missing
The stock is already down about 15% in 2023 as the pharmaceutical giant gets set to report earnings.
IDEXX Laboratories Is Barking Up the Right Tree
Here's how we'd play the stock of this pet healthcare name.
Abbott Laboratories Not Yet in the Clear as We Approach Earnings
The charts suggest a bit of caution may be needed in the days ahead. Let's take a look.
Johnson & Johnson Might Need a Band-Aid Ahead of Earnings
A rally in the shares stalled around $180 in December and early January.
Bearish Bets: 3 Nasdaq Giants You Should Think About Shorting This Week
These stocks are displaying bearish tendencies based on their technical patterns.
This Small Pharma Company Could Develop Into a Nice Trade
Let's see how to trade GlycoMimetics, a clinical-stage drug developer focused on a type of cancer treatment.
Incyte Gets a Quantitative Upgrade
We have two price target areas for this biopharmaceutical firm.
As Celldex Recovers, Here's My Strategy
Let's check the charts on this clinical stage drug developer.
Moderna Shares Surge on Promising Vaccine Results
Let's check the charts and indicators.
Inflation, Crude Oil, Big Mac(ro) Attack, Tough Market, Defense Stocks, Pharma
Wednesday morning will bring traders, investors, Romans, and countrymen more macroeconomic results than they could ever wanted to peruse at one time.